Heme, heme oxygenase, and ferritin: How the vascular endothelium survives (and dies) in an iron-rich environment

Antioxidants and Redox Signaling

Volumn 9, Issue 12, 2007, Pages 2119-2137

  Balla, József ^a,e   Vercellotti, Gregory M ^b   Jeney, Viktória ^a   Yachie, Akihiro ^c   Varga, Zsuzsa ^a   Jacob, Harry S ^b   Eaton, John W ^d   Balla, György ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c KANAZAWA UNIVERSITY   (Japan)

^d UNIVERSITY OF LOUISVILLE   (United States)

^e NONE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; FERRITIN; HEME; HEME OXYGENASE; HEME OXYGENASE 1; HEMOGLOBIN; IRON; LOW DENSITY LIPOPROTEIN; PORPHYRIN; REACTIVE OXYGEN METABOLITE;

CELL DEATH; CELL KILLING; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKOCYTE; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; CELL DEATH; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FERRITINS; HEME; HEME OXYGENASE-1; HEMOGLOBINS; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MODELS, BIOLOGICAL; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 35848957274     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1787     Document Type: Review

References (141)

1. Abraham NG, Lavrovsky Y, Schwartzman ML, Stoltz RA, Levere RD, Gerritsen ME, Shibahara S, and Kappas A. Transfection of the human heme oxygenase gene into rabbit coronary microvessel endothelial cells: protective effect against heme and hemoglobin toxicity. Proc Natl Acad Sci U S A 92: 6798-6802, 1995.
2. Abraham NG, Mitrione SM, Hodgson WJ, Levere RD, and Shibahara S. Expression of heme oxygenase in hemopoiesis. Adv Exp Med Biol 241: 97-116, 1988.
3. Agarwal A, Balla J, Balla G, Croatt AJ, Vercellotti, GM, and Nath KA. Renal tubular epithelial cells mimic endothelial cells upon exposure to oxidized LDL. Am J Physiol 271: 814-823, 1996.
4. Alam J and Smith A. Heme-hemopexin-mediated induction of metallothionein gene expression. J Biol Chem 267: 16379-16384, 1992.
5. Applegate LA, Scaletta C, Panizzon R, Frenk E, Hohlfeld P, and Schwarzkopf S. Induction of the putative protective protein ferritin by infrared radiation: implications in skin repair. Int J Mol Med 5: 247-251, 2000.
6. Bak I, Szendrei L, Turoczi T, Papp G, Joo F, Das DK, de Leiris J, Der P, Juhasz B, Varga E, Bacskay I, Balla J, Kovacs P, and Tosaki A. Heme oxygenase-1-related carbon monoxide production and ventricular fibrillation in isolated ischemic/reperfused mouse myocardium. FASEB J 17: 2133-2135, 2003.
7. Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, Eaton JW, and Vercellotti GM. Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem 267: 18148-18153, 1992.
8. Balla G, Jacob HS, Eaton JW, Belcher JD, and Vercellotti GM. Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial cell injury. Arterioscler Thromb 11: 1700-1711, 1991.
9. Balla G, Vercellotti G, Eaton JW, and Jacob HS. Heme uptake by endothelium synergizes polymorphonuclear granulocyte-mediated damage. Trans Assoc Am Physicians 103: 174-917, 1990.
10. Balla G, Vercellotti GM, Eaton JW, and Jacob HS. Iron loading of endothelial cells augments oxidant damage. J Lab Clin Med 116: 546-554, 1990.
11. Balla G, Vercellotti GM, Muller-Eberhard U, Eaton J, and Jacob HS. Exposure of endothelial cells to free heme potentiates damage mediated by granulocyte and toxic oxygen species. Lab Invest 64: 648-655, 1991.
12. Balla J, Balla G, Jeney V, Kakuk G, Jacob H S, and Vercellotti G . Ferriporphyrins and endothelium: a 2-edged sword; promotion of oxidation and induction of cytoprotectants. Blood 95: 3442-3450, 2000.
13. Balla J, Balla G, Kakuk G, Agarwal A, and Nath KA. Endothelial cell heme oxygenase and ferritin induction by heme- and copper-catalyzed oxidation of LDL [Abstract]. J Invest Med 43: 376A, 1995.
14. Balla J, Jacob HS, Balla G, Nath K, and Vercellotti GM. Endothelial cell heme oxygenase and ferritin induction by heme proteins: a possible mechanism limiting shock damage. Trans Assoc Am Physicians 105: 1-6, 1992.
15. Balla J, Jacob HS, Balla G, Nath K, Eaton JW, and Vercellotti GM. Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci U S A 90: 9285-9289, 1993.
16. Balla J, Nath K, Balla G, Juckett MB, Jacob HS, and Vercellotti GM. Endothelial cell heme oxygenase and ferritin induction in rat lung by hemoglobin in vivo. Am J Physiol 268: 321-327, 1995.
17. Balla J, Vercellotti GM, Jeney V, Yachie A, Varga Z, Eaton JW, and Balla G. Heme, heme oxygenase and ferritin in vascular endothelial cell injury. Mol Nutr Food Res 49: 1030-1043, 2005.
18. Bamm VV, Tsemakhovich VA, Shaklai M, and Shaklai N. Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL. Biochemistry 43: 3899-3906, 2004.
19. Baranano DE, Rao M, Ferris CD, and Snyder SH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci U S A 99: 16093-16098, 2002.
20. Beaumont C, Dugast I, Renaudie F, Souroujon M, and Grandchamp B. Transcriptional regulation of ferritin H and L subunits in adult erythroid and liver cells from the mouse: unambiguous identification of mouse ferritin subunits and in vitro formation of the ferritin shells. J Biol Chem 264: 7498-7504, 1989.
21. Berberat PO, Katori M, Kaczmarek E, Anselmo D, Lassman C, Ke B, Shen X, Busuttil RW, Yamashita K, Csizmadia E, Tyagi S, Otterbein LE, Brouard S, Tobiasch E, Bach FH, Kupiec-Weglinski JW, and Soares MP. Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. FASEB J 17: 1724-1726, 2003.
22. Broxmeyer HE, Cooper S, Levi S, and Arosio P. Mutated recombinant human heavy-chain ferritins and myelosuppression in vitro and in vivo: link between ferritin ferroxidase activity and biological function. Proc Natl Acad Sci U S A 88: 770-774, 1991.
23. Bunn HF and Jandl JH. Exchange of heme among hemoglobins and between hemoglobin and albumin. J Biol Chem 243: 465-475, 1968.
24. Byrnes RW and Petering DH. Inhibition of bleomycin-induced cellular DNA strand scission by 1,10-phenanthroline. Biochem Pharmacol l41: 1241-1248, 1991.
25. Camejo G, Halberg C, Manschik-Lundin A, Hurt-Camejo E, Rosengren B, Olsson H, Hansson GI, Forsberg GB, and Ylhen B. Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages. J Lipid Res 39: 755-766, 1998.
26. Cazzola M, Bergamaschi G, Dezza L, and Arosio P. Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation. Blood 75: 1903-1919, 1990.
27. Cermak J, Balla J, Jacob HS, Balla G, Enright H, Nath K, and Vercellotti GM. Tumor cell heme uptake induces ferritin synthesis resulting in altered oxidant sensitivity: possible role in chemotherapy efficacy. Cancer Res 53: 5308-5313, 1993.
28. Clark JE, Foresti R, Sarathchandra P, Kaur H, Green CJ, and Motterlini R. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol 278: 643-651, 2000.
29. Coccia EM, Profita V, Fiorucci G, Romeo G, Affabris E, Testa U, Hentze MW, and Battistini A. Modulation of ferritin H-chain expression in Friend erythroleukemia cells: transcriptional and translational regulation by hemin. Mol Cell Biol 12: 3015-3022, 1992.
30. Coffey MD, Cole RA, Colles SM, and Chisolm GM. In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid and peroxyl radicals. J Clin Invest 96: 1866-1873, 1995.
31. Cozzi A, Corsi B, Levi S, Santambrogio P, Albertini A, and Arosio P. Overexpression of wild type and mutated human ferritin Hchain in HeLa cells: in vivo role of ferritin ferroxidase activity. J Biol Chem 275: 25122-25129, 2000.
32. Dallegri F, Ballestrero A, Frumento G, and Patrone F. Augmentation of neutrophil-mediated erythrocyte lysis by cells derived in vitro from human monocytes. Blood 70:1743-1749, 1987.
33. Delanghe J, Cambier B, Langlois M, De Buyzere M, Neels H, De Bacquer D, and Van Cauwelaert P. Haptoglobin polymorphism, a genetic risk factor in coronary artery bypass surgery. Atherosclerosis 132: 215-219, 1997.
34. Dennery PA, Spitz DR, Yang G, Tatarov A, Lee CS, Shegog ML, and Poss KD. Oxygen toxicity and iron accumulation in the lungs of mice lacking heme oxygenase-2. J Clin Invest 101: 1001-1011, 1998.
35. Dickey LF, Wang YH, Shull GE, Wortman IA, and Theil EC. The importance of the 3′-untranslated region in the translational control of ferritin mRNA. J Biol Chem 263: 3071-3074, 1988.
36. Dore S, Takahashi M, Ferris CD, Zakhary R, Hester LD, Guastella D, and Snyder SH. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci U S A 96: 2445-2450, 1999.
37. Dulak J, Jozkowicz A, Foresti R, Kasza A, Frick M, Huk I, Green CJ, Pachinger O, Weidinger F, and Motterlini R. Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid Redox Signal 4: 229-240, 2002.
38. el-Saadani M, Esterbauer H, el-Sayed M, Goher M, Nassar AY, and Jurgens G. A spectrophotometric assay for lipid peroxidation in serum lipoproteins using a commercially available reagent. J Lipid Res 30: 627-630, 1989.
39. Epsztejn S, Glickstein H, Picard V, Slotki IN, Beaumont C, and Cabantchik ZI. H-ferritin subunit overexpression in erythroid cells reduces the oxidative stress response and induces multidrug resistance properties. Blood 94: 3593-3603, 1999.
40. Eskew JD, Vanacore RM, Sung L, Morales PJ, and Smith A. Cellular protection mechanisms against extracellular heme: heme-hemopexin, but not free heme, activates the N-terminal c-jun kinase. J Biol Chem 274: 638-648, 1999.
41. Esterbauer H, Gebicki J, Puhl H, and Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 13: 341-390, 1992.
42. Esterbauer H, Striegl G, Puhl H, and Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 6: 67-75, 1989.
43. Ewing JF, Haber SN, and Maines MD. Normal and heat-induced patterns of expression of heme oxygenase-1 (HSP32) in rat brain: hyperthermia causes rapid induction of mRNA and protein. J Neurochem 58: 1140-1149, 1992.
44. Faulk WP, Hsi BL, and Stevens PJ. Transferrin and transferrin receptors in carcinoma of the breast. Lancet 2: 390-392, 1980.
45. Fonseca AM, Pereira CF, Porto GP, and Arosa FA. Red blood cells upregulate cytoprotective proteins and the labile iron pool in dividing human T cells despite a reduction in oxidative stress. Free Radic Biol Med 35: 1404-1416, 2003.
46. Foresti R, Bains S, Sulc F, Farmer PJ, Green CJ, and Motterlini R. The interaction of nitric oxide with distinct hemoglobins differentially amplifies endothelial heme uptake and heme oxygenase-1 expression. J Pharmacol Exp Ther 317: 1125-1133, 2006.
47. Foresti R, Hoque M, Bains S, Green CJ, and Motterlini R. Haem and nitric oxide: synergism in the modulation of the endothelial haem oxygenase-1 pathway. Biochem J 372: 381-390, 2003.
48. Gannon DE, Varani J, Phan SH, Ward JH, Kaplan J, Till GO, Simon RH, Ryan US, and Ward PA. Source of iron in neutrophil-mediated killing of endothelial cells. Lab Invest 57: 37-44, 1987.
49. Giulivi C and Cadenas E. Heme protein radicals: formation, fate, and biological consequences. Free Radic Biol Med 24: 269-279, 1998.
50. Gladwin MT, Crawford JH, and Patel RP. The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation. Free Radic Biol Med 36: 707-717, 2004.
51. Goralska M, Holley BL, and McGahan MC. Overexpression of H- and L-ferritin subunits in lens epithelial cells: Fe metabolism and cellular response to UVB irradiation. Invest Ophthalmol Vis Sci 42: 1721-1727, 2001.
52. Graca-Souza AV, Arruda MA, de Freitas MS, Barja-Fidalgo C, and Oliveira PL. Neutrophil activation by heme: implications for inflammatory processes. Blood 99: 4160-4165, 2002.
53. Güner G, Kirkali G, Yenisey C, and Tore IR. Cytosol and serum ferritin in breast carcinoma. Cancer Lett 67:103-112, 1992.
54. Gutteridge JM and Smith A. Antioxidant protection by haemopexin of haem-stimulated lipid peroxidation. Biochem J 256: 861-865, 1988.
55. Gutteridge JM. The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation. Biochim Biophys Acta 917: 219-223, 1987.
56. Halliwell B and Gutteridge JMC. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 219: 1-14, 1984.
57. Hamilton TA, Wada HG, and Sussman HH. Identification of transferrin receptors on the surface of human cultured cells. Proc Natl Acad Sci U S A 76: 6406-6410, 1979.
58. Harrison PM and Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1275: 161-203, 1996.
59. Hennig B and Chow CK. Lipid peroxidation and endothelial cell injury: implications in atherosclerosis. Free Radic Biol Med 4: 99-105, 1988.
60. Hill-Kapturczak N, Voakes C, Garcia J, Visner G, Nick HS, and Agarwal A. A cis-acting region regulates oxidized lipid-mediated induction of the human heme oxygenase-1 gene in endothelial cells. Arterioscler Thromb Vasc Biol 23: 1416-1422, 2003.
61. Hogg N, Rice-Evans C, Darley-Usmar V, Wilson MT, Paganga G, and Bourne L. The role of lipid hydroperoxides in the myoglobin-dependent oxidation of LDL. Arch Biochem Biophys 314: 39-44, 1994.
62. Hunter GC, Dubick MA, Keen CL, and Eskelson CD. Effects of hypertension on aortic antioxidant status in human abdominal aneurysmal and occlusive disease. Proc Soc Exp Biol Med 196: 273-279, 1991.
63. Irwin KC, Chisolm GM, Ma G, Irwin KC, Martin LL, Gunderson KG, Linberg LF, Morel DW, and DiCorleto PE. 7β-Hydroperoxycholest-5-en-3β-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. Proc Natl Acad Sci U S A 91: 11452-11456, 1994.
64. Jeney V, Balla J, Yachie A, Varga Z, Vercellotti GM, and Balla G. Pro-oxidant and cytotoxic effects of circulating heme. Blood 100: 879-887, 2002.
65. Juckett MB, Balla J, Balla G, Jessurun J, Jacob HS, and Vercellotti GM. Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro. Am J Pathol 147: 782-789, 1995.
66. Kawashima A, Oda Y, Yachie A, Koizumi S, and Nakanishi I. Heme oxygenase-1 deficiency: the first autopsy case. Hum Pathol 33: 125-130, 2002.
67. Keyse SM and Tyrrell RM. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblast by UVA radiation, hydrogen peroxide, and sodium arsenate. Proc Natl Acad Sci U S A 86: 99-103, 1989.
68. Kim YS and Dore S. Catalytically inactive heme oxygenase-2 mutant is cytoprotective. Free Radic Biol Med 39: 558-564, 2005.
69. Kino K, Tsunoo H, Higa Y, Takami M, Hamaguchi H, and Nakajima H. Hemoglobin-haptoglobin receptor in rat liver plasma membrane. J Biol Chem 255: 9616-9620, 1980.
70. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, and Moestrup SK. Identification of the hemoglobin scavenger receptor. Nature 409: 198-201, 2001.
71. Kuhn H, Belkner J, Zaiss S, Fahrenklemper T, and Wohlfeil S. Involvement of 15-lipoxygenase in early stages of atherogenesis. J Exp Med 179: 1903-1911, 1994.
72. Laskey J, Webb I, Schulman HM, and Ponka P. Evidence that transferrin supports cell proliferation by supplying iron for DNA synthesis. Exp Cell Res 176: 87-95, 1988.
73. Lawson DM, Treffry A, Artymiuk PJ, Harrison PM, Yewdall SJ, Luzzago A, Cesareni G, Levi S, and Arosio P. Identification of the ferroxidase centre in ferritin. FEBS Lett 254: 207-210, 1989.
74. Lee PJ, Alam J, Wiegand GW, and Choi AM. Overexpression of heme oxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia. Proc Natl Acad Sci U S A 93: 10393-10398, 1996.
75. Li W, Dalen H, Eaton JW, and Yuan XM. Apoptotic death of inflammatory cells in human atheroma. Atheroscler Thromb Vasc Biol 21: 1124-1130, 2001.
76. Lin F and Girotti AW. Elevated ferritin production, iron containment, and oxidant resistance in hemin-treated leukemia cells. Arch Biochem Biophys 346: 131-141, 1997.
77. Lin F and Girotti AW. Hemin-enhanced resistance of human leukemia cells to oxidative killing: antisense determination of ferritin involvement. Arch Biochem Biophys 352: 51-58, 1998.
78. Lin F and Girotti AW. Hyperresistance of leukemia cells to photodynamic inactivation after long-term exposure to hemin. Cancer Res 56: 4636-4643, 1996.
79. Lin JJ, Daniels-McQueen S, Patino MM, Gaffield L, Walden WE, and Thach RE. Depression of ferritin messenger RNA translation by hemin in vitro. Science 247: 74-77, 1990.
80. Maines MD and Kappas A. Cobalt induction of hepatic heme oxygenase; with evidence that cytochrome P-450 in not essential for this enzyme activity. Proc Natl Acad Sci U S A 71: 4293-4297, 1974.
81. Maples KR, Kennedy CH, Jordan SJ, and Mason RP. In vivo thiyl free radical formation from hemoglobin following administration of hydroperoxides. Arch Biochem Biophys 277: 402-409, 1990.
82. Miller YI, Altamentova SM, and Shaklai N. Oxidation of low-density lipoprotein by hemoglobin stems from a heme-initiated globin radical: antioxidant role of haptoglobin. Biochemistry 36: 12189-12198, 1997.
83. Miller YI and Shaklai N. Oxidative crosslinking of LDL protein induced by hemin: involvement of tyrosines. Biochem Mol Biol Int 34: 1121-1129, 1994.
84. Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE, and Green CJ. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res 90: 17-24, 2002.
85. Motterlini R, Foresti R, Intaglietta M, and Winslow RM. NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol 270: H107-H114, 1996.
86. Naughton P, Foresti R, Bains SK, Hoque M, Green CJ, and Motterlini R. Induction of heme oxygenase 1 by nitrosative stress: a role for nitroxyl anion. J Biol Chem 277: 40666-40674, 2002.
87. Nagy E, Jeney V, Yachie A, Szabo RP, Wagner O, Vercellotti GM, Eaton JW, Balla G, and Balla J. Oxidation of hemoglobin by lipid hydroperoxide associated with low-density lipoprotein (LDL) and increased cytotoxic effect by LDL oxidation in heme oxygenase-1 (HO-1) deficiency. Cell Mol Biol (Noisy-le-grand) 51: 377-385, 2005.
88. Nath KA, Balla G, Vercellotti GM, Balla J, Jacob HS, Levitt MD, and Rosenberg ME. Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 90: 267-270, 1992.
89. Nath KA, Balla J, Croatt AJ, and Vercellotti GM. Heme protein-mediated renal injury: a protective role for 21-aminosteroids in vitro and in vivo. Kidney Int 47: 592-602, 1995.
90. Oberle S, Polte T, Abate A, Podhaisky HP, and Schroder H. Aspirin increases ferritin synthesis in endothelial cells: a novel antioxidant pathway. Circ Res 82: 1016-1020, 1998.
91. Otterbein L, Chin BY, Otterbein SL, Lowe VC, Fessler HE, and Choi AM. Mechanism of hemoglobin-induced protection against endotoxemia in rats: a ferritin-independent pathway. Am J Physiol 272: 268-275, 1997.
92. Otterbein L, Sylvester SL, and Choi AM. Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1. Am J Respir Cell Mol Biol 13: 595-601, 1995.
93. Otterbein LE, Kolls JK, Mantell LL, Cook JL, Alam J, and Choi AM. Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest 103: 1047-1054, 1999.
94. Otterbein LE, Mantell LL, and Choi AM. Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol 276: 688-694, 1999.
95. Paganga G, Rice-Evans C, Rule R, and Leake D. The interaction between ruptured erythrocytes and low-density lipoproteins. FEBS Lett 303: 154-158, 1992.
96. Pahl PM, Horwitz MA, Horwitz KB, and Horwitz LD. Desferriexochelin induces death by apoptosis in human breast cancer cells but does not kill normal breast cells. Breast Cancer Res Treat 69: 69-79, 2001.
97. Paller MS and Jacob HS. Cytochrome P-450 mediates tissue-damaging hydroxyl radical formation during reoxygenation of the kidney. Proc Natl Acad Sci U S A 91: 7002-7006, 1994.
98. Ponka P. Cell biology of heme. Am J Med Sci 318: 241-256, 1999.
99. Poss KD and Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci U S A 94:10919-10924, 1997.
100. Poss KD and Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci U S A 94: 10925-10930, 1997.
101. Regan RF, Kumar N, Gao F, and Guo Y. Ferritin induction protects cortical astrocytes from heme-mediated oxidative injury. Neuroscience 113: 985-994, 2002.
102. Regnstrom L, Nilsson L, Tornvall P, Landou C, and Hamsten A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 339: 1183-1186, 1992.
103. Reif DW and Simmons RD. Nitric oxide mediates iron release from ferritin. Arch Biochem Biophys 283: 537-541, 1990.
104. Reif DW. Ferritin as a source of iron for oxidative damage. Free Radic Biol Med 12: 417-427, 1992.
105. Repine JE, Fox RB, and Berger EM. Hydrogen peroxide kills Staphylococcus aureus by reacting with staphylococcal iron to form hydroxyl radical. J Biol Chem 256: 7094-7096, 1981.
106. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 340: 115-126, 1999.
107. Rothfuss A and Speit G. Investigations on the mechanism of hyperbaric oxygen (HBO)-induced adaptive protection against oxidative stress. Mutation Res 508: 157-165, 2002.
108. Sadrzadeh SM and Eaton JW. Hemoglobin-mediated oxidant damage to the central nervous system requires endogenous ascorbate. J Clin Invest 82: 1510-1515, 1988.
109. Sadrzadeh SM, Graf E, Panter SS, Hallaway PE, and Eaton JW. Hemoglobin: a biologic Fenton reagent. J Biol Chem 259: 14354-14356, 1984.
110. Sato K, Balla J, Otterbein L, Smith RN, Brouard S, Lin Y, Csizmadia E, Sevigny J, Robson SC, Vercellotti G, Choi AM, Bach FH, and Soares MP. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 166: 4185-4194, 2001.
111. Savenkova ML, Mueller DM, and Heinecke JW. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J Biol Chem 269: 20394-20400, 1994.
112. Shibahara S, Yoshida T, and Kikuchi G. Induction of heme oxygenase by hemin in cultured pig alveolar macrophages. Arch Biochem Biophys 188: 243-250, 1978.
113. Smith A. Links between cell-surface events involving redox-active copper and gene regulation in the hemopexin heme transport system. Antioxid Redox Signal 2: 157-175, 2000.
114. Smith C, Mitchinson MJ, Aruoma OI, and Halliwell B. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem J 286: 901-905, 1992.
115. Smith ML, Paul J, Ohlosson PI, Hjortsberg K, and Paul KG. Heme-protein fission under nondenaturing conditions. Proc Natl Acad Sci U S A 88: 882-886, 1991.
116. Soares MP, Lin Y, Anrather J, Csizmadia E, Takigami K, Sato K, Grey ST, Colvin RB, Choi AM, Poss KD, and Bach FH. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 4: 1073-1077, 1998.
117. Sparrow CP, Parthasarathy S, and Steinberg D. Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification. J Lipid Res 29: 745-753, 1988.
118. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, and Witztum IL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320: 915-924, 1989.
119. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, and Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043-1046, 1987.
120. Suzuki H, Muramutsu M, Kojima T, and Taki W. Intracranial heme metabolism and cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 34: 2796-2800, 2003.
121. Takeshita M, Grollman AP, Ohtsubo E, and Ohtsubo H. Interaction of bleomycin with DNA. Proc Natl Acad Sci U S A 75: 5983-5987, 1978.
122. Taylor JL, Carraway MS, and Piantadosi CA. Lung-specific induction of heme oxygenase-1 and hyperoxic lung injury. Am J Physiol 274: 582-905, 1998.
123. Tenhunen R, Marver HS, and Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A 61: 748-755, 1968.
124. Thomas CE and Aust SD. Reductive release of iron from ferritin by cation free radicals or paraquat and other bipyridyls. J Biol Chem 261: 13064-13070, 1986.
125. Thomas CE, Morehouse LE, and Aust SD. Ferritin and superoxide dependent lipid peroxidation. J Biol Chem 260: 3275-3280, 1985.
126. Ujhelyi L, Balla G, Jeney V, Varga Z, Nagy E, Vercellotti GM, Agarwal A, Eaton JW, and Balla J. Hemodialysis reduces inhibitory effect of plasma ultrafiltrate on LDL oxidation and subsequent endothelial reactions. Kidney Int 69: 144-151, 2006.
127. Ujhelyi L, Balla J, Muszbek L, Kakuk G, Belcher J, Jacob HS, Vercellotti GM, and Balla G. A microassay to assess the oxidative resistance of low-density lipoproteins. Clin Chem 44: 1762-1764, 1998.
128. Van Lenten BJ, Prieve J, Navab M, Hama S, Lusis AJ, Fogelman AM. Lipid-induced changes in intracellular iron homeostasis in vitro and in vivo. J Clin Invest 95: 2104-2110, 1995.
129. Vandewalle B, Granier AM, Peyrat JP, Bonneterre J, and Lefebvre J. Transferrin receptors in cultured breast cancer cells. J Cancer Res Clin Oncol 110: 71-76, 1985.
130. Vile GF, Basu-Modak S, Waltner C, and Tyrell RM. Heme oxygenase 1 mediates an adaptive response to oxidative stress in human skin fibroblast. Proc Natl Acad Sci U S A 91: 2607-2610, 1994.
131. Wagener FA, Eggert A, Boerman OC, Oyen WJ, Verhofstad A, Abraham NG, Adema G, van Kooyk Y, de Witte T, and Figdor CG. Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood 98: 1802-1811, 2001.
132. Wagener, Feldman E, de Witte T, and Abraham NG. Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cells. Proc Soc Exp Biol Med 216: 456-463, 1997.
133. Wang L, Lee T, Lee F, Pai R, and Chau L. Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 152: 711-720, 1998.
134. Weinberg ED. Roles of iron in neoplasia: promotion, prevention and therapy. Biol Trace Elem Res 34: 923-940, 1992.
135. Weiss SJ. Neutrophil-mediated methemoglobin formation in the erythrocyte: the role of superoxide and hydrogen peroxide. J Biol Chem 257: 2947-2953, 1982.
136. White K and Munro HN. Induction of ferritin subunit synthesis by iron is regulated at both the transcriptional and translational levels. J Biol Chem 263: 8938-8942, 1988.
137. Wieland E, Parthasarathy S, and Steinberg D. Peroxidase-dependent metal-independent oxidation of low density lipoprotein in vitro: a model for in vivo oxidation? Proc Natl Acad Sci U S A 90: 5929-5933, 1993.
138. Witztum J and Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88: 1785-1792, 1991.
139. Wu J, Hua Y, Keep RF, Nakamura T, Hoff JT, and Xi G. Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke 34: 2964-2969, 2003.
140. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, and Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103: 129-135, 1999.
141. Ziouzenkova O, Asatryan L, Akmal M, Tetta C, Wratten, ML, Loseto-Wich G, Jurgens G, Heinecke J, and Sevanian A. Oxidative cross-linking of ApoB100 and hemoglobin results in low density lipoprotein modification in blood: relevance to atherogenesis caused by hemodialysis. J Biol Chem 274: 18916-18924, 1999.